Clinical Trials List
Protocol Number201600097A0
2016-03-31 - 2020-06-30
Others
Terminated1
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- See-Tong Pang Division of Hematology & Oncology
- 范綱行 Division of Radiation Therapy
- Tzu-Chen Yen Division of Nuclear Medicine
- 吳桂芳 Division of Others
- 洪志宏 Division of Radiation Therapy
- 詹頂立 Division of Radiation Therapy
- 王俐人 Division of Radiology
- 張英勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
72 participants
-
Global
0 participants
